Daniel Hartley
Daniel Hartley is the Editor in Chief of Business News & Info, overseeing editorial strategy and content standards across the publication. With a background in business and financial journalism, Daniel leads the team in delivering accurate, timely business news for a global audience.
Latest by Daniel Hartley(9 articles)
PBC Treatment Market to Hit $2.72 Billion by 2032
The global Primary Biliary Cholangitis treatment market is projected to reach $2.72 billion by 2032, driven by rising prevalence and advanced therapies.
about 3 hours ago
Litecoin Stalls Below $45 Amid ETF Hopes as Meme Coins Surge
Litecoin's price stalls below $45, but a 95% chance of an ETF by November 2024 offers hope. Meanwhile, new meme coin PEPEto sees significant presale gains.
about 15 hours ago
JAK1 Inhibitor Market Poised for Double-Digit Growth
The global JAK1 inhibitor drug market is projected to reach $3.6 billion by 2033, driven by increasing autoimmune disease prevalence and drug development.
about 21 hours ago
AlphaPepe Leads Crypto Presale Surge Amidst Market Uncertainty
AlphaPepe's presale success signals a shift towards early-stage crypto investments amid market fear, with other projects also gaining traction.
about 24 hours ago
ICE Box Claims Unveils Document Security System
ICE Box Claims introduced its ICE Box Personal Document Storage System, offering secure organization and protection for vital documents during emergencies.
1 day ago
Manassas Chiropractor Adopts Low-Force Adjusting Methods
Manassas chiropractor Dr. Gyzel Tabrizi uses low-force instrument adjusting techniques, offering a gentle yet precise alternative for spinal and joint care.
1 day ago
Solana Price Stalls Amid Market Volatility, Meme Coin Surge
Solana's price stabilizes near $68 amid market volatility and a surge in new meme coin projects.
2 days ago
BAS Tools Market Poised for Significant Growth by 2035
The global Breach and Attack Simulation (BAS) tools market is set for significant growth through 2035, driven by escalating cyber threats and regulatory demands. Proactive security validation is becoming essential for businesses worldwide.
2 days ago
ADMA Biologics Faces Class Action Over Alleged Misstatements
ADMA Biologics faces a class action lawsuit over alleged misleading statements about its operations and FDA compliance, with investors having until July 15 to act.
2 days ago